JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M206360200 on August 8, 2002

J. Biol. Chem., Vol. 277, Issue 42, 39953-39959, October 18, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/42/39953    most recent
M206360200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gallois-Montbrun, S.
Right arrow Articles by Veron, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallois-Montbrun, S.
Right arrow Articles by Veron, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Improving Nucleoside Diphosphate Kinase for Antiviral Nucleotide Analogs Activation*

Sarah Gallois-MontbrunDagger §, Benoit SchneiderDagger §, Yuxing Chen||, Véronique Giacomoni-FernandesDagger , Laurence Mulard**, Solange Morera||, Joël Janin||, Dominique Deville-BonneDagger Dagger Dagger , and Michel VeronDagger

From the Dagger  Régulation Enzymatique des Activités Cellulaires, CNRS FRE 2364, Institut Pasteur, 25, rue du Dr. Roux 75724, Paris cedex 15, the || Laboratoire d'Enzymologie et Biochimie Structurales, CNRS UPR 9063, Gif-sur Yvette 91198, and the ** Unité de Chimie Organique, CNRS URA 1228, Institut Pasteur, 25, rue du Dr. Roux 75724, Paris cedex 15, France

Antiviral nucleoside analog therapies rely on their incorporation by viral DNA polymerases/reverse transcriptase leading to chain termination. The analogs (3'-deoxy-3'-azidothymidine (AZT), 2',3'-didehydro-2',3'-dideoxythymidine (d4T), and other dideoxynucleosides) are sequentially converted into triphosphate by cellular kinases of the nucleoside salvage pathway and are often poor substrates of these enzymes. Nucleoside diphosphate (NDP) kinase phosphorylates the diphosphate derivatives of the analogs with an efficiency some 104 lower than for its natural substrates. Kinetic and structural studies of Dictyostelium and human NDP kinases show that the sugar 3'-OH, absent from all antiviral analogs, is required for catalysis. To improve the catalytic efficiency of NDP kinase on the analogs, we engineered several mutants with a protein OH group replacing the sugar 3'-OH. The substitution of Asn-115 in Ser and Leu-55 in His results in an NDP kinase mutant with an enhanced ability to phosphorylate antiviral derivatives. Transfection of the mutant enzyme in Escherichia coli results in an increased sensitivity to AZT. An x-ray structure at 2.15-Å resolution of the Dictyostelium enzyme bearing the serine substitution in complex with the Rp-alpha -borano-triphosphate derivative of AZT shows that the enhanced activity reflects an improved geometry of binding and a favorable interaction of the 3'-azido group with the engineered serine.


* This work was supported by funds from Agence Nationale de la Recherche contre le SIDA and from SIDACTION-Ensemble-contre-le-SIDA.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The atomic coordinates and the structure factors (code 1MN7) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

§ Both authors contributed equally to this work.

present address: Laboratoire de Differenciation Cellulaire et Prions, CNRS-UPR 1983, 7 rue Guy Môquet, 94801 Villejuif cedex, France.

Dagger Dagger To whom correspondence should be addressed. Tel.: 33-1-40-61-35-35; Fax: 33-1-45-68-83-99; E-mail: ddeville@pasteur.fr.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. A. Kaminski, P. Dacher, L. Dugue, and S. Pochet
In Vivo Reshaping the Catalytic Site of Nucleoside 2'-Deoxyribosyltransferase for Dideoxy- and Didehydronucleosides via a Single Amino Acid Substitution
J. Biol. Chem., July 18, 2008; 283(29): 20053 - 20059.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
J.-D. Pedelacq, G. S. Waldo, S. Cabantous, E. C. Liong, and T. C. Terwilliger
Structural and functional features of an NDP kinase from the hyperthermophile crenarchaeon Pyrobaculum aerophilum
Protein Sci., October 1, 2005; 14(10): 2562 - 2573.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
L. De Bolle, L. Naesens, and E. De Clercq
Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy
Clin. Microbiol. Rev., January 1, 2005; 18(1): 217 - 245.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.